The Hidden Cost of Stability: Reversing Antipsychotic-induced Cognitive Impairment
Source PublicationCell Host & Microbe
Primary AuthorsZheng, Yan, Hao et al.

The Static in the Signal
For many, the heavy fog of antipsychotic-induced cognitive impairment is the price paid for sanity. While these drugs quiet the storms of psychosis, they often leave the mind sluggish, blurring the edges of memory and focus. Millions rely on these prescriptions to navigate daily life, yet the resulting cognitive erosion often forces a choice between mental clarity and emotional safety.
These results were observed under controlled laboratory conditions, so real-world performance may differ.
A Path to Prevent Antipsychotic-induced Cognitive Impairment
Researchers found that chronic treatment with drugs like olanzapine changes the gut's internal world. The study measured a sharp drop in ergothioneine, an antioxidant normally produced by certain bacteria. When these microbes vanish, the brain's hippocampus loses its defence against oxidative stress.
A Molecular Shield
The data suggests a specific chain reaction:
- Drugs deplete Cyanobacteria, the primary producers of ergothioneine.
- This deficiency allows the protein PTP1B to damage synapses.
- Supplementing the diet with ergothioneine protected the mice from memory loss.
Restoring the Mind
This work suggests the cognitive toll of medicine may be avoidable. By protecting the gut or blocking the PTP1B protein, clinicians might recognise a way to preserve the clarity of patients. The findings, validated in both mice and human blood samples, provide a map for future therapies to ensure the cost of stability is no longer the loss of self.